Fig. 5From: How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?Mean relevance of Europe’s Beating Cancer Plan with regards to each stakeholder group’s activities (scale 1 [low relevance] to 5 [high relevance])Back to article page